STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Lifemd Inc Stock Price, News & Analysis

LFMD Nasdaq

Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.

LifeMD, Inc. (LFMD) operates a leading telehealth platform connecting patients with HIPAA-compliant care solutions. This page serves as the definitive source for verified company news, providing investors and healthcare professionals with timely updates on key developments.

Access consolidated information on earnings reports, strategic partnerships, regulatory milestones, and service expansions. Our curated news collection simplifies tracking LFMD's progress in digital prescription services, remote diagnostics, and integrated telehealth solutions.

Discover updates across three core areas: financial performance announcements, operational developments in WorkSimpli software solutions, and advancements in secure patient-provider communication technologies. All content is sourced from official releases and trusted financial publications.

Bookmark this page for efficient monitoring of LifeMD's innovations in cloud-based pharmacy services, nutritional supplement offerings, and telehealth infrastructure. Return regularly to stay informed about this evolving leader in virtual healthcare delivery.

Rhea-AI Summary

LifeMD, Inc.® (Nasdaq: LFMD) partners with Withings Health Solutions to enhance virtual patient care for GLP-1 weight-loss patients. By providing advanced in-home health monitoring devices, LifeMD aims to improve patient outcomes through real-time data, drive compliance, and enhance clinical decision-making. This partnership sets a new standard in virtual care, revolutionizing weight management patient care and supporting chronic care management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.3%
Tags
none
-
Rhea-AI Summary

LifeMD, Inc. announced the appointment of Dr. Calum MacRae, a renowned clinician and researcher at Harvard Medical School, to its Board of Directors. Dr. MacRae's expertise in cardiology and chronic disease management will enhance the company's virtual primary care services. His track record in implementing innovative solutions and leveraging technology in healthcare is expected to drive LifeMD's growth and improve patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.9%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.34%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.85%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.95%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
conferences

FAQ

What is the current stock price of Lifemd (LFMD)?

The current stock price of Lifemd (LFMD) is $5.42 as of November 4, 2025.

What is the market cap of Lifemd (LFMD)?

The market cap of Lifemd (LFMD) is approximately 272.2M.
Lifemd Inc

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

272.18M
38.94M
15.82%
53.97%
11.82%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK